When

Samstag, 25. April 2026 um 19:00 Uhr

Where

Bechstein Network Atelier, Prinzenstr. 85D, 10969 Berlin


Speaker
Andrea Jungaberle Clinical Advisor to the Board


INSIGHT Forum (EN): Beyond Reductionism in Psychedelic Research?

We are honored to welcome renowned psychologist and neuroscientist Dr. Christopher Timmermann (UCL Centre for Consciousness Research), medical doctor and head of the OVID Clinic Berlin Dr. Andrea Jungaberle, former patient Steffi Küster, and the sound collective Soneiro as our guests for the twentieth INSIGHT Forum - which will also be an occasion to celebrate the publication of the EPIsoDE study and the Compassionate Use license, both concerning psilocybin-assisted psychotherapy. Two major steps for clinical research into psychedelic substances. 

Join us for an evening about the "fundamental tension" of psychedelic research, set against the stunning backdrop of Berlin’s skyline. 

The MIND Foundation’s INSIGHT Forum returns to Berlin for a special evening at the Bechstein Atelier, a breathtaking loft at Moritzplatz. This event bridges the gap between metaphysical inquiry, cutting-edge neuroscience, and the lived reality of the therapeutic process:

Program

1. Transrationale: Sonic Contemplation (19:15)
We begin the evening by moving beyond the analytical mind. The Berlin-based music collective Soneiro will lead a 20-minute sound meditation. Through immersive frequencies and contemplation, we create a space of presence before diving into the intellectual discourse.

2. Rationale: The Middle Way of Psychedelics (19:45)
The scientific segment features a keynote by Dr. Christopher Timmermann (Imperial College London / UCL). Addressing the current "epistemological halt" in the field, Dr. Timmermann will propose a "middle-way approach." He explores how current research on neuroplasticity and subjective experience challenges 1st- and 3rd-person reductionisms, arguing that the fundamental tension in psychedelic science is, at its core, metaphysical. In this context, he will also talk about his DMT research.

Following the keynote, we shift from theory to the clinical frontline. Dr. med. Andrea Jungaberle, Medical Director of OVID Clinic Berlin, the first facility in the EU licensed to legally perform psilocybin-augmented psychotherapy, will engage in a dialogue with Steffi Küster. As a former patient, Steffi will provide the essential patient perspective, shedding light on the subjective journey within a professional medical framework. The session concludes with an interactive Q&A, inviting the audience to join the discourse.

3. Communitas: Connection & Drinks (21:00)
Reflect on the insights of the evening and connect with the community. Enjoy drinks and networking in the architectural elegance of the Bechstein Network Atelier as we overlook the lights of Berlin.

Check out the fantastic location here.

The event will be moderated by Simon Reichersdörfer and Dr. Marvin Däumichen.

Newsletter